Review



bioactive compound library  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    TargetMol bioactive compound library
    Bioactive Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 110 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Bioactive+Compound+Library/pmc10985106-204-9-14
    Average 95 stars, based on 110 article reviews
    bioactive compound library - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: Cell Painting in activated cells illuminates phenotypic dark space and drug mechanisms of action
    Article Snippet: We obtained a library of 8,387 bioactive compounds (L4000-CUST, listed in Supplementary Data 1) from TargetMol.

    Article Title: P2Y12-oriented computational screening and functional validation identify antiplatelet compounds with antithrombotic activity.
    Article Snippet: AutoDock Vina10 was used to dock the compound into the protein pocket and choose the best docking pose for the next analysis.

    Article Title: MD2-IN-1 restores microglial lysosomal function and attenuates amyloid pathology through TREM2-associated signaling in 5×FAD mice.
    Article Snippet: Triggering receptor expressed on myeloid cells 2 (TREM2) is a central regulator of microglial adaptation during Alzheimer’s disease (AD), yet the development of small-molecule modulators associated with TREM2 signaling remains limited.. Here, through a consensus pharmacophore-guided virtual screening strategy, MD2-IN-1 was identified as a candidate small molecule associated with TREM2 signaling.. Biolayer interferometry and cellular thermal shift assays supported cellular target engagement related to TREM2 (KD= 13.85 μM).

    Positive Control:

    Article Title: A Multifunctional Electrospun Membrane for Full-Thickness Abdominal Wall Defect Repair.
    Article Snippet: Electrospun nanofiber membranes hold promise for abdominal wall repair due to their biomimetic architecture and tunable properties.. However, their porous structure often induces an elevated foreign body response (FBR) that impedes tissue integration and remodeling.. While previous strategies have employed ibuprofen (IBU) to mitigate inflammation, its nonselective cyclooxygenase (COX) inhibition and rapid systemic clearance limit local therapeutic efficacy.

    Article Title: Use of pyrido[1,2-a]pyrimidone analogue
    Article Snippet: F12 Culture medium (purchased from Gibco, product number: 11765-054); (3) Test Article and Positive Control Article Test article: compound I; Positive control article: Cisplatin, molecular weight: 300.05; solvent: PBS (phosphate buffer saline); storage condition: 2-8° C.; supplier: Qilu Pharmaceutical. .. Positive control article: Alpelisib, molecular weight: 441.47; solvent: DMSO; supplier: Shanghai TOPSCIENCE Biochemical Technology Co., Ltd., CAS number: 1217486-61-7; 2. ..

    Membrane:

    Article Title: A Multifunctional Electrospun Membrane for Full-Thickness Abdominal Wall Defect Repair.
    Article Snippet: Electrospun nanofiber membranes hold promise for abdominal wall repair due to their biomimetic architecture and tunable properties.. However, their porous structure often induces an elevated foreign body response (FBR) that impedes tissue integration and remodeling.. While previous strategies have employed ibuprofen (IBU) to mitigate inflammation, its nonselective cyclooxygenase (COX) inhibition and rapid systemic clearance limit local therapeutic efficacy.

    Sterility:

    Article Title: A Multifunctional Electrospun Membrane for Full-Thickness Abdominal Wall Defect Repair.
    Article Snippet: Electrospun nanofiber membranes hold promise for abdominal wall repair due to their biomimetic architecture and tunable properties.. However, their porous structure often induces an elevated foreign body response (FBR) that impedes tissue integration and remodeling.. While previous strategies have employed ibuprofen (IBU) to mitigate inflammation, its nonselective cyclooxygenase (COX) inhibition and rapid systemic clearance limit local therapeutic efficacy.

    Molecular Weight:

    Article Title: Use of pyrido[1,2-a]pyrimidone analogue
    Article Snippet: F12 Culture medium (purchased from Gibco, product number: 11765-054); (3) Test Article and Positive Control Article Test article: compound I; Positive control article: Cisplatin, molecular weight: 300.05; solvent: PBS (phosphate buffer saline); storage condition: 2-8° C.; supplier: Qilu Pharmaceutical. .. Positive control article: Alpelisib, molecular weight: 441.47; solvent: DMSO; supplier: Shanghai TOPSCIENCE Biochemical Technology Co., Ltd., CAS number: 1217486-61-7; 2. ..

    Solvent:

    Article Title: Use of pyrido[1,2-a]pyrimidone analogue
    Article Snippet: F12 Culture medium (purchased from Gibco, product number: 11765-054); (3) Test Article and Positive Control Article Test article: compound I; Positive control article: Cisplatin, molecular weight: 300.05; solvent: PBS (phosphate buffer saline); storage condition: 2-8° C.; supplier: Qilu Pharmaceutical. .. Positive control article: Alpelisib, molecular weight: 441.47; solvent: DMSO; supplier: Shanghai TOPSCIENCE Biochemical Technology Co., Ltd., CAS number: 1217486-61-7; 2. ..

    Drug discovery:

    Article Title: Targeting the CD4 + effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosis.
    Article Snippet: .. A library of approximately 20,000 bioactive compounds (TargetMol Bioactive Compound Library) was prepared using the LigPrep module (Schrödinger, LLC, New York, NY, 2021). ..

    Article Title: Discovery of tepotinib as a novel LY75-targeting small-molecule inhibitor with anti-tumor activity in ovarian cancer via virtual screening
    Article Snippet: .. Preprocessing of the small-molecule library and virtual screening The commercially available TargetMol Bioactive Compound Library (L4000), containing 17,284 small molecules, was used in this study. ..

    Screening:

    Article Title: Discovery of tepotinib as a novel LY75-targeting small-molecule inhibitor with anti-tumor activity in ovarian cancer via virtual screening
    Article Snippet: .. Preprocessing of the small-molecule library and virtual screening The commercially available TargetMol Bioactive Compound Library (L4000), containing 17,284 small molecules, was used in this study. ..



    Similar Products

    96
    Zymo Research ms2 internal positive control
    Ms2 Internal Positive Control, supplied by Zymo Research, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Positive+Control/med_rxiv__64898__2026__10__09__26365131-37-23-18
    Average 96 stars, based on 1 article reviews
    ms2 internal positive control - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    ATCC positive controls
    Positive Controls, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Pseudomonas+aeruginosa+(Schroeter)+Migula/pmc13694517-93-50-55
    Average 99 stars, based on 1 article reviews
    positive controls - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Gilead Sciences positive control inhibitor remdesivir
    Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)
    Positive Control Inhibitor Remdesivir, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/VEKLURY/pmc13688729-188-6-9
    Average 99 stars, based on 1 article reviews
    positive control inhibitor remdesivir - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    Beyotime tunel assay kit
    Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)
    Tunel Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Positive+Control+Preparation+Kit+for+TUNEL+Assay/pm42860508-556-7-10
    Average 94 stars, based on 1 article reviews
    tunel assay kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Zymo Research positive control dna
    Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)
    Positive Control Dna, supplied by Zymo Research, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Positive+Control/bio_rxiv__64898__2026__10__07__757507-90-0-10
    Average 96 stars, based on 1 article reviews
    positive control dna - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Zymo Research dna based positive control
    Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)
    Dna Based Positive Control, supplied by Zymo Research, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Positive+Control/10__1093_slash_ismeco_slash_ycag292-69-5-8
    Average 96 stars, based on 1 article reviews
    dna based positive control - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Zymo Research mock community positive control
    Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)
    Mock Community Positive Control, supplied by Zymo Research, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Positive+Control/pm42826892-105-1-8
    Average 96 stars, based on 1 article reviews
    mock community positive control - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    ATCC k pneumoniae atcc 35657 positive control
    Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)
    K Pneumoniae Atcc 35657 Positive Control, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/Klebsiella+pneumoniae+subsp%2E+pneumoniae+(Schroeter)+Trevisan/pmc13673014-47-13-15
    Average 95 stars, based on 1 article reviews
    k pneumoniae atcc 35657 positive control - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    ATCC positive control snu449 cell line
    SBT777101 demonstrates minimal antigen-specific activation without impact on normal human cell survival. (A) Representative flow cytometry plots showing surface (top) and intracellular (bottom) binding of SBT777101 scFv-Fc (right) relative to isotype control (left) in <t>SNU449</t> cells. (B) In vitro functional characterization using SNU449 cells ± CV-beads. Left: Mean ± SD CD69 expression (only SBT777101 data shown; no activation observed in UT controls). Data analyzed by two-way ANOVA with Sidak’s multiple comparisons test. Right: Cytotoxicity measured as the number of viable target cells remaining, normalized to no-Treg controls. Data analyzed by one-way ANOVA with Tukey’s multiple comparisons test. (C) Percentage of UT (top) or SBT777101 (bottom) Tregs expressing CD69 after 24-h co-culture with normal human primary cells or CV-beads (positive control). Data represent mean ± SD from three replicates. Independent experiments are separated by dashed vertical lines. Comparisons were made for media alone compared with in the presence of primary cells for each type and analyzed by two-tailed unpaired t -test. (D) Cytotoxicity (mean ± SD) of SBT777101 and UT Tregs against the same primary cell panel, normalized to no-Treg controls. Data analyzed by one-way ANOVA with Tukey’s multiple comparisons test. (E) Fold-change in CD71 expression (mean ± SD; relative to media control) across three donors after 72-h culture with media, CitP − SKNBE2 cells, CitP + SNU449 cells, human brain astrocytes (HBA), or CV-beads. CV beads were prepared in RPMI or AGM media as appropriate. Full lysis controls (B, D) represent target cells treated with Triton X-100. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. All experiments included 3 technical replicates. AGM, astrocyte growth medium; CitP, citrullinated protein; CV, citrullinated vimentin; HMEC, human mammary epithelial cells; NHBE, normal human bronchial epithelial cells; NHDF, normal human dermal fibroblasts; PrEC, prostate epithelial cells; RPTEC, renal proximal tubule epithelial cells; scFv, single-chain variable fragment; UT, untransduced.
    Positive Control Snu449 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/positive+control/SNU-449/pmc13637847-74-56-60
    Average 96 stars, based on 1 article reviews
    positive control snu449 cell line - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)

    Journal: BMC Pharmacology & Toxicology

    Article Title: The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication

    doi: 10.1186/s40360-026-01264-3

    Figure Lengend Snippet: Docking scores and ΔG bind (Prime MM-GBSA) values of panel compounds towards the binding sites of two other SARS-CoV-2 targets: M pro (PDB ID: 7L0D) and RdRp (PDB ID:7BV2)

    Article Snippet: This activity approached that of the positive control inhibitor remdesivir, which inhibited 85.8 ± 11.4% of virus replication at 10 μM, which in turn is consistent with its previously reported EC 50 of 7.3 μM by us in this assay [ ].

    Techniques: Docking Assay, Binding Assay

    Dose-response curves of oleanolic acid ( A ), poinsettifolin B ( B ), and rhuschalcone III ( C ) indicating ability to inhibit SARS-CoV-2 replication in infected Vero cells (green) and cell viability in uninfected Vero cells (violet). In these experiments, control inhibitor remdesivir inhibited 85.8 ± 11.4% replication at 10 µM, consistent with its previously reported EC 50 of 7.3 µM in this assay

    Journal: BMC Pharmacology & Toxicology

    Article Title: The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication

    doi: 10.1186/s40360-026-01264-3

    Figure Lengend Snippet: Dose-response curves of oleanolic acid ( A ), poinsettifolin B ( B ), and rhuschalcone III ( C ) indicating ability to inhibit SARS-CoV-2 replication in infected Vero cells (green) and cell viability in uninfected Vero cells (violet). In these experiments, control inhibitor remdesivir inhibited 85.8 ± 11.4% replication at 10 µM, consistent with its previously reported EC 50 of 7.3 µM in this assay

    Article Snippet: This activity approached that of the positive control inhibitor remdesivir, which inhibited 85.8 ± 11.4% of virus replication at 10 μM, which in turn is consistent with its previously reported EC 50 of 7.3 μM by us in this assay [ ].

    Techniques: Infection, Control

    SBT777101 demonstrates minimal antigen-specific activation without impact on normal human cell survival. (A) Representative flow cytometry plots showing surface (top) and intracellular (bottom) binding of SBT777101 scFv-Fc (right) relative to isotype control (left) in SNU449 cells. (B) In vitro functional characterization using SNU449 cells ± CV-beads. Left: Mean ± SD CD69 expression (only SBT777101 data shown; no activation observed in UT controls). Data analyzed by two-way ANOVA with Sidak’s multiple comparisons test. Right: Cytotoxicity measured as the number of viable target cells remaining, normalized to no-Treg controls. Data analyzed by one-way ANOVA with Tukey’s multiple comparisons test. (C) Percentage of UT (top) or SBT777101 (bottom) Tregs expressing CD69 after 24-h co-culture with normal human primary cells or CV-beads (positive control). Data represent mean ± SD from three replicates. Independent experiments are separated by dashed vertical lines. Comparisons were made for media alone compared with in the presence of primary cells for each type and analyzed by two-tailed unpaired t -test. (D) Cytotoxicity (mean ± SD) of SBT777101 and UT Tregs against the same primary cell panel, normalized to no-Treg controls. Data analyzed by one-way ANOVA with Tukey’s multiple comparisons test. (E) Fold-change in CD71 expression (mean ± SD; relative to media control) across three donors after 72-h culture with media, CitP − SKNBE2 cells, CitP + SNU449 cells, human brain astrocytes (HBA), or CV-beads. CV beads were prepared in RPMI or AGM media as appropriate. Full lysis controls (B, D) represent target cells treated with Triton X-100. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. All experiments included 3 technical replicates. AGM, astrocyte growth medium; CitP, citrullinated protein; CV, citrullinated vimentin; HMEC, human mammary epithelial cells; NHBE, normal human bronchial epithelial cells; NHDF, normal human dermal fibroblasts; PrEC, prostate epithelial cells; RPTEC, renal proximal tubule epithelial cells; scFv, single-chain variable fragment; UT, untransduced.

    Journal: Toxicological Sciences

    Article Title: Nonclinical safety assessment of SBT777101, a CAR-engineered regulatory T cell therapy for autoimmune diseases

    doi: 10.1093/toxsci/kfag125

    Figure Lengend Snippet: SBT777101 demonstrates minimal antigen-specific activation without impact on normal human cell survival. (A) Representative flow cytometry plots showing surface (top) and intracellular (bottom) binding of SBT777101 scFv-Fc (right) relative to isotype control (left) in SNU449 cells. (B) In vitro functional characterization using SNU449 cells ± CV-beads. Left: Mean ± SD CD69 expression (only SBT777101 data shown; no activation observed in UT controls). Data analyzed by two-way ANOVA with Sidak’s multiple comparisons test. Right: Cytotoxicity measured as the number of viable target cells remaining, normalized to no-Treg controls. Data analyzed by one-way ANOVA with Tukey’s multiple comparisons test. (C) Percentage of UT (top) or SBT777101 (bottom) Tregs expressing CD69 after 24-h co-culture with normal human primary cells or CV-beads (positive control). Data represent mean ± SD from three replicates. Independent experiments are separated by dashed vertical lines. Comparisons were made for media alone compared with in the presence of primary cells for each type and analyzed by two-tailed unpaired t -test. (D) Cytotoxicity (mean ± SD) of SBT777101 and UT Tregs against the same primary cell panel, normalized to no-Treg controls. Data analyzed by one-way ANOVA with Tukey’s multiple comparisons test. (E) Fold-change in CD71 expression (mean ± SD; relative to media control) across three donors after 72-h culture with media, CitP − SKNBE2 cells, CitP + SNU449 cells, human brain astrocytes (HBA), or CV-beads. CV beads were prepared in RPMI or AGM media as appropriate. Full lysis controls (B, D) represent target cells treated with Triton X-100. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. All experiments included 3 technical replicates. AGM, astrocyte growth medium; CitP, citrullinated protein; CV, citrullinated vimentin; HMEC, human mammary epithelial cells; NHBE, normal human bronchial epithelial cells; NHDF, normal human dermal fibroblasts; PrEC, prostate epithelial cells; RPTEC, renal proximal tubule epithelial cells; scFv, single-chain variable fragment; UT, untransduced.

    Article Snippet: Primary human cells (mammary epithelial cells [HMEC; Lonza Cat#CC-2551], normal bronchial epithelial cells [NHBE; Lonza Cat#CC2451], renal proximal tubule epithelial cells [RPTEC; Lonza Cat#CC2553], prostate epithelial cells [PrEC; Lonza Cat#CC2555], hepatocytes [Lonza Cat#HUCPG], brain astrocytes [HBA; Neuromics Cat#HMP202], iPSC-derived myocytes [Tempo Bioscience Cat#1014], iPSC-derived cortical neurons [Tempo Bioscience Cat#201], and monocyte-derived macrophages [internally derived]) and the positive-control SNU449 cell line (ATCC Cat#CRL-2234) were assessed for binding of the SBT777101 scFv by flow cytometry.

    Techniques: Activation Assay, Flow Cytometry, Binding Assay, Control, In Vitro, Functional Assay, Expressing, Co-culture Assay, Positive Control, Two Tailed Test, Lysis